Triple

T9863635
Position Surface form Disambiguated ID Type / Status
Subject Rutgers Biomedical and Health Sciences E239776 entity
Predicate hasPart P35 FINISHED
Object Center for Advanced Biotechnology and Medicine
The Center for Advanced Biotechnology and Medicine is a Rutgers research institute focused on cutting-edge biomedical science and biotechnology to improve human health.
E239776 NE FINISHED

Disambiguation candidates (2 decisions)

The exact options the model was shown at each disambiguation step, with the option it chose highlighted — the evidence behind this triple's disambiguated ids.

NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Center for Advanced Biotechnology and Medicine
Context triple: [Rutgers Biomedical and Health Sciences, hasPart, Center for Advanced Biotechnology and Medicine]
  • A. Center for Cellular and Molecular Therapeutics
    The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
  • B. Center for Biotechnology and Interdisciplinary Studies
    The Center for Biotechnology and Interdisciplinary Studies is a major research facility focused on cutting-edge biotechnology and cross-disciplinary scientific collaboration.
  • C. Feinstein Institutes for Medical Research
    The Feinstein Institutes for Medical Research is a leading biomedical research organization in New York focused on advancing medical science and improving patient care through translational and clinical research.
  • D. Rutgers Biomedical and Health Sciences
    Rutgers Biomedical and Health Sciences is the division of Rutgers University that encompasses its medical, dental, nursing, pharmacy, public health, and allied health schools and research institutes.
  • E. Center for Health and Biosciences
    The Center for Health and Biosciences is a research and policy institute focused on health care, biomedical innovation, and related public policy issues.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Center for Advanced Biotechnology and Medicine
Target entity description: The Center for Advanced Biotechnology and Medicine is a Rutgers research institute focused on cutting-edge biomedical science and biotechnology to improve human health.
  • A. Center for Cellular and Molecular Therapeutics
    The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
  • B. Center for Biotechnology and Interdisciplinary Studies
    The Center for Biotechnology and Interdisciplinary Studies is a major research facility focused on cutting-edge biotechnology and cross-disciplinary scientific collaboration.
  • C. Feinstein Institutes for Medical Research
    The Feinstein Institutes for Medical Research is a leading biomedical research organization in New York focused on advancing medical science and improving patient care through translational and clinical research.
  • D. Rutgers Biomedical and Health Sciences chosen
    Rutgers Biomedical and Health Sciences is the division of Rutgers University that encompasses its medical, dental, nursing, pharmacy, public health, and allied health schools and research institutes.
  • E. Center for Health and Biosciences
    The Center for Health and Biosciences is a research and policy institute focused on health care, biomedical innovation, and related public policy issues.
  • F. None of above.

Provenance (5 batches)

Stage Batch ID Job type Status
creating batch_69ca84e7506c819095cbde4ff16512bb elicitation completed
NER batch_69cdb3b927d08190a45ff68de3954e8f ner completed
NED1 batch_69d1e447d3dc819090268f7d14ba3be4 ned_source_triple completed
NED2 batch_69d1e5358b148190a6e432aac9d02544 ned_description completed
NEDg batch_69d1e4bdd10881909d03bac4912e8e0a nedg completed
Created at: March 30, 2026, 8:35 p.m.